Call for ideas to partner with GSK


Monday, 15 September, 2014

GSK is calling on scientists, researchers, innovators and start-up companies to submit ideas to the Open Innovation challenge. Ideas that match specific criteria will have the chance to partner with GSK and be developed through to commericalisation.

Ideas will need to be health-related and in the areas of nutrition, wellness, oral health or skin health. Successful entrants will be provided with resources and support to potentially turn their idea into a commercial reality.

GSK has a proven track record of turning inspired product ideas into household names. For example, Sensodyne Repair and Protect toothpaste began as an initiative by two Florida dentists, who adapted US military technology for mending bones into an oral health solution. This created NovaMin which, combined with saliva and water, crystallises to form a mineral similar to natural tooth mineral. GSK saw the potential in the innovation and built a partnership with the team. Together they developed the first daily toothpaste to repair sensitive teeth, which has helped millions of people with tooth sensitivity.

GSK Innovation healthcare spokesperson Montse Pena said that GSK is excited to be promoting this opportunity to innovators in Australia and New Zealand.

“We feel certain there are bright, new healthcare product ideas in this part of the world that just need support to progress to the next level. We offer Australian and New Zealand innovators the reach, resources, scientific development and world-class marketing to help their product ideas become a commercial success.”

Submissions can be made via the Open Innovation website

Related News

Common arthritis drug also lowers blood pressure

Scientists have known for a while that methotrexate helps with inflammation, but it may also help...

AI enables precise gene editing

A newly developed tool utilises AI to predict how cells repair their DNA after it is cut by gene...

Shingles vaccine may reduce risk of heart attack and stroke 

Vaccination with either the recombinant herpes zoster vaccine or the live-attenuated zoster...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd